Surviving The 'Magic Microscope' Test

Law360, New York (August 4, 2011, 1:57 PM EDT) -- In a long-awaited decision issued July 29, 2011, the federal appeals court responsible for patent matters reversed a lower court decision that had threatened to eliminate all "gene patents." In the case of Association for Molecular Pathology v. Myriad Genetics a three-judge panel of the Court of Appeals for the Federal Circuit in large part overturned a New York federal district court decision from last April. The suit had been brought by several medical societies, physicians and individual cancer patients, seeking to invalidate several so-called "gene patents" held by Myriad Genetics and the University of Utah....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!